GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

INCY · Sep 30, 2021

INCYTE CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001558370-21-014131General Corporate
Inventory pressure80thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

2.62% · OPTIONAL · VALID

Gross margin60thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.gross_margin

95.10% · CORE · VALID

Operating margin90thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.operating_margin

28.96% · CORE · VALID

R&D intensity0thOwn-history percentile · N=10
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

41.20% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=10
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

5.25% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesSelf-history eligible
Period transition

What moved in the state?

Inventory Pressure Increased
Previous
2.36%
Current
2.62%
Delta
0.26%
Margin Increased
Previous
94.61%
Current
95.10%
Delta
0.48%
Profitability Increased
Previous
19.96%
Current
28.96%
Delta
9.00%
R And D Intensity Decreased
Previous
48.68%
Current
41.20%
Delta
-7.48%
Sbc Intensity Decreased
Previous
6.35%
Current
5.25%
Delta
-1.10%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.